AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 6,949.2%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 6,949.18% |
Nexalin Technology (NXLIW) | 1,730.99% |
Binah Capital Group, Inc Warrants (BCGWW) | 1,292.17% |
SRAX (SRAX) | 1,263.64% |
Codere Online Luxembourg SA Warrants (CDROW) | 1,144.7% |
Palladyne AI (PDYNW) | 999% |
Bone Biologics Corp Warrants (BBLGW) | 967.45% |
Versus Systems (VSSYW) | 966.67% |
Fitell Corporation Ordinary Shares (FTEL) | 872.37% |
GeneDx (WGS) | 851.11% |
OneMedNet (ONMDW) | 810% |
AdTheorent (ADTHW) | 809.09% |
AGBA Acquisition (AGBA) | 644.59% |
Corbus Pharmaceuticals (CRBP) | 629.95% |
LENZ Therapeutics (LENZ) | 586.79% |
Elevation Oncology (ELEV) | 557.41% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
Kernel (KRNLW) | 513.21% |
Landos Biopharma (LABP) | 511.47% |
Data Storage (DTSTW) | 511.11% |
Biofrontera Inc Warrants (BFRIW) | 500% |
Armada Acquisition Corp I Warrant (AACIW) | 499.5% |
Inception Growth Acquisition Limited Warrants (IGTAW) | 494.74% |
Swvl (SWVL) | 481.25% |
iPower (IPW) | 477.78% |